ATUM is a biologics development services company based in the San Francisco Bay Area, specializing in gene design and synthesis, antibody production and engineering, cell line development (including CHO and HEK platforms), and protein expression and analytics. ATUM provides services from virtual sequence to research cell bank, leveraging machine learning and proprietary technologies like Leap-In Transposase for cell line development. They partner with CDMOs like AGC Biologics but do not themselves perform drug substance or drug product manufacturing.
gene synthesis, cell line development, protein expression, antibody engineering, machine learning-based sequence optimization, Leap-In Transposase technology
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.